204 results
Page 3 of 11
6-K
EX-99.1
4ivzh8k cdf
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
keioa5 j4
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
6-K
EX-99.2
suhz3 xgqtbgv3v6xhlb
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
cx6q73 3bx
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
qofiwqj
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.2
7wfj630p8m9 39ngq
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.1
2r56j ukofy3b5
21 Oct 21
Current report (foreign)
3:49pm
6-K
EX-99.1
ax06btxc8p
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.2
s351u4p40t9tsopbvsx
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.1
zcd6puymq0z
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.5
awgmqocp
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.7
5bp9xrz nyq1xe1iu6
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
dcr837br
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
c1ssygik4
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.3
7tx3tjltq
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
q6ghkzkb2o
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
r5bug1plrts
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
8j0 dkfa1ht5
13 Aug 21
51-102F3 Material Change Report
12:00am